Risks And Uncertainties Include

WAYNE, BloodVitals SPO2 PA (February 24, BloodVitals tracker 2016) - LifeScan, Inc. has launched the new OneTouch Verio Flex™ blood glucose monitoring system, BloodVitals SPO2 with ColorSure™ technology - a easy, BloodVitals SPO2 accurate and BloodVitals SPO2 simple-to-use meter that takes the guesswork out of understanding blood sugar test outcomes for BloodVitals SPO2 folks with diabetes. Its simple shade vary indicator makes use of colour to instantly inform patients when their blood glucose readings are "low," "in vary," or "high" to allow them to quickly get on with their lives. Nine out of 10 folks with diabetes agreed that the meter’s coloration vary indicator Blood Vitals helped them simply interpret their blood sugar readings. While it has broad enchantment as a easy, intuitive meter on its own, BloodVitals SPO2 patients may also use the meter’s built-in Bluetooth® Smart Technology to wirelessly join with the companion OneTouch Reveal® cellular app available on compatible iOS and blood oxygen monitor Android cellular gadgets. "Research reveals that ease of use stays an important cause for meter selection by a majority of patients while, at the same time, one third say they can’t make sense of their blood sugar results," stated Dr. Jeremy Pettus, Endocrinologist and BloodVitals SPO2 Assistant Professor BloodVitals SPO2 of Medicine on the University of California, San Diego.



"The new OneTouch Verio Flex™ meter is designed to assist folks with diabetes higher perceive and manage their blood glucose. The low and high vary limits set within the OneTouch Verio Flex™ meter might be customized for every patient based mostly on their healthcare professional’s suggestions. With every test, the easy color range indicator reveals whether or not a result's under limit (blue), within vary (inexperienced) or above the restrict (pink). Nine out of 10 healthcare professionals agreed that understanding when their readings are in or out of vary could assist patients reach their blood sugar goals and keep in higher management. Currently, there are an estimated 29 million people with diabetes in the US and plenty of don’t take a look at their blood sugar usually or as advisable by their healthcare professional. Seven out of 10 people with diabetes agreed that the OneTouch Verio Flex™ meter with its easy colour vary indicator might encourage them to test as really useful.



The OneTouch Verio®IQ meter that spots patterns and helps patients perceive how insulin, meals and life-style have an effect on their numbers. LifeScan has begun shipping the new OneTouch Verio Flex™ system to retailers and it'll soon be obtainable nationally wherever diabetes testing provides are bought with an estimated retail worth of $19.99. OneTouch® is essentially the most really helpful model by endocrinologists and major care physicians. LifeScan, Inc. is part of the Johnson & Johnson Diabetes Care Companies. With a shared vision of making a world with out limits for individuals with diabetes, the Johnson & Johnson Diabetes Care Companies is a collaboration of Johnson & Johnson firms devoted to diabetes and contains LifeScan, Inc., a world leader in blood glucose monitoring; Animas Corporation, maker of progressive insulin supply systems; and Calibra Medical, Inc., developer of a singular 3-day wearable insulin patch pump. In the US, LifeScan, Inc. is the main maker of blood glucose monitoring methods and its OneTouch® brand products are advisable by more endocrinologists and main care physicians than any other brand.



Globally, greater than 10 million people depend upon OneTouch® brand products for easy testing and accurate outcomes to assist them manage their diabetes. This press release comprises "forward-looking statements" as outlined within the Private Securities Litigation Reform Act of 1995 relating to the new OneTouch Verio Flex™ blood glucose monitoring system. The reader is cautioned to not rely on these forward-looking statements. These statements are based on current expectations of future occasions. If underlying assumptions show inaccurate or known or unknown dangers or uncertainties materialize, actual results may differ materially from the expectations and projections of LifeScan, Inc. and/or Johnson & Johnson. Risks and uncertainties embrace, but should not limited to: uncertainty of commercial success; challenges to patents; competition, including technological advances, new merchandise and patents attained by opponents; modifications to applicable laws and rules, including global well being care reforms; adjustments in conduct and spending patterns or monetary distress of purchasers of well being care services; product efficacy or security concerns leading to product recalls or regulatory action; manufacturing difficulties and delays; and traits toward well being care price containment.